Page last updated: 2024-08-05 11:21:19
cyclic peptide
null
ChEBI ID: 23449
Members (11)
Member | Definition | Role |
---|---|---|
2,5-dioxopiperazine | A cyclic peptide that is piperazine in which the hydrogens at positions 2 and 5 are replaced by oxo groups. | piperazine-2,5-dione |
ascidiacyclamide | Ascidiacyclamide | |
bq 123 | BQ 123 | |
lypressin | (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacy | |
malformins | Malformin | |
patellamide a | Patellamide A | |
patellamide b | Patellamide B | |
patellamide c | Patellamide C | |
patellamide d | Patellamide D | |
westiellamide | Westiellamide | |
wewakazole | Wewakazole |
Research
Studies (2,854)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 624 (21.86) | 18.7374 |
1990's | 940 (32.94) | 18.2507 |
2000's | 762 (26.70) | 29.6817 |
2010's | 461 (16.15) | 24.3611 |
2020's | 67 (2.35) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 238 (7.87%) | 5.53% |
Reviews | 238 (7.87%) | 6.00% |
Case Studies | 165 (5.46%) | 4.05% |
Observational | 4 (0.13%) | 0.25% |
Other | 2,379 (78.67%) | 84.16% |